Status: Not yet recruiting
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
The primary objective of this trial is to evaluate the clinical efficacy of ATH-063 in participants with biologic/advanced therapy relapsed/refractory moderately to severely active UC.
Participants needed: 120
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Athos Therapeutics IncUpdated: Jun 8, 2026Locations: 2
Eligibility criteria
Able to understand and willing to provide informed consent and able to comply wi... [+16]
Clinically significant abnormal medical history, or abnormal findings on physica... [+26]